Group 1 - The company plans to sell a 47% stake in Suzhou Medical Device Industry Development Group Co., Ltd. to Suzhou High-tech Zone State-owned Capital Holding Group Co., Ltd. for 604 million yuan [1][2] - Suzhou Medical Device Industry Company, established in May 2009, has a registered capital of approximately 995 million yuan and focuses on medical devices, biotechnology, and pharmaceutical research [1][2] - The company reported a revenue of 152 million yuan and a net loss of 81.81 million yuan for the fiscal year 2024, with a revenue of 140 million yuan and a net loss of 101 million yuan for the first three quarters of 2025 [1][2] Group 2 - The transaction is based on an asset appraisal report, with the total equity value of Suzhou Medical Device Industry Company assessed at 1.286 billion yuan, reflecting a 12.93% increase over the book value [2] - The payment will be made in installments, with 51% of the transfer payment due by January 7, 2026, and the remaining 49% by March 31, 2026 [2] - Suzhou High-tech Zone State-owned Capital Holding Group has total assets of 88.924 billion yuan and equity of 8.098 billion yuan as of September 30, 2025, indicating sufficient payment capability [2] Group 3 - The sale of the stake is intended to reduce the impact of the medical device industry company's performance on the company's financial statements and enhance overall profitability [3] - The company will continue to manage existing funds and projects while focusing on quality enterprises in the medical device sector and promoting green low-carbon industrial park operations [3]
苏州高新拟出售 医疗器械产业公司47%股权